chartexchange

Avalyn to Present at Upcoming Investor Conferences

GlobeNewswire Inc. | Nov 3, 2026 8:00 AM EST

BOSTON, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc. (Nasdaq: AVLN), a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm of serious, rare respiratory diseases, today announced its participation in the following upcoming investor conferences:

Read original article